Cargando…
Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease
Despite the growing number of new drugs approved for the treatment of inflammatory bowel disease (IBD), the long-term clinical use of thiopurine therapy and the well-known properties of conventional drugs including azathioprine have made their place in IBD therapy extremely valuable. Despite the fac...
Autores principales: | Lazarević, Slavica, Đanic, Maja, Al-Salami, Hani, Mooranian, Armin, Mikov, Momir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016117/ https://www.ncbi.nlm.nih.gov/pubmed/35450035 http://dx.doi.org/10.3389/fphar.2022.879170 |
Ejemplares similares
-
Editorial: Pharmacokinetic evaluation and modeling of clinically significant drug metabolites, Volume II
por: Mikov, Momir, et al.
Publicado: (2023) -
Bioaccumulation and biotransformation of simvastatin in probiotic bacteria: A step towards better understanding of drug-bile acids-microbiome interactions
por: Đanić, Maja, et al.
Publicado: (2023) -
Transport and Biotransformation of Gliclazide and the Effect of Deoxycholic Acid in a Probiotic Bacteria Model
por: Ðanić, Maja, et al.
Publicado: (2019) -
Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
por: Ðanić, Maja, et al.
Publicado: (2018) -
Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles
por: Pavlović, Nebojša, et al.
Publicado: (2018)